These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38931931)

  • 1. Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.
    Ponzini E; Astolfi G; Grandori R; Tavazzi S; Versura P
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
    Wu KY; Joly-Chevrier M; Akbar D; Tran SD
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.
    Lynch C; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
    Polymers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery.
    Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Isabel Lema M; Otero-Espinar FJ
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
    Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
    J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin-loaded contact lenses: eye protection against oxidative stress.
    Pastori V; Tavazzi S; Lecchi M
    Cornea; 2015 Jun; 34(6):693-7. PubMed ID: 25961493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes.
    López-Machado A; Díaz N; Cano A; Espina M; Badía J; Baldomà L; Calpena AC; Biancardi M; Souto EB; García ML; Sánchez-López E
    Int J Pharm; 2021 Nov; 609():121188. PubMed ID: 34655707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular drug delivery systems: An overview.
    Patel A; Cholkar K; Agrahari V; Mitra AK
    World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.
    Wu KY; Ashkar S; Jain S; Marchand M; Tran SD
    Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
    Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterial-based ophthalmic drug delivery.
    Xie G; Lin S; Wu F; Liu J
    Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery.
    Qi Q; Wei Y; Zhang X; Guan J; Mao S
    J Control Release; 2023 Sep; 361():191-211. PubMed ID: 37532148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
    Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.
    Dubald M; Bourgeois S; Andrieu V; Fessi H
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29342879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Drug Delivery: Present Innovations and Future Challenges.
    Gote V; Sikder S; Sicotte J; Pal D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.